Diagnostic Challenges of Amyloidosis in Waldenström Macroglobulinemia

Morel, 2009, International prognostic scoring system for Waldenstrom macroglobulinemia, Blood, 113, 4163, 10.1182/blood-2008-08-174961 Merlini, 2006, Dangerous small B-cell clones, Blood, 108, 2520, 10.1182/blood-2006-03-001164 Merlini, 2008, Amyloidosis: is a cure possible?, Ann Oncol, 19, iv63, 10.1093/annonc/mdn200 Merlini, 2012, Differential diagnosis of monoclonal gammopathy of undetermined significance, Hematology Am Soc Hematol Educ Program, 2012, 595, 10.1182/asheducation.V2012.1.595.3798563 Gertz, 1993, Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia, J Clin Oncol, 11, 914, 10.1200/JCO.1993.11.5.914 Gertz, 2003, Amyloidosis with IgM monoclonal gammopathies, Semin Oncol, 30, 325, 10.1053/sonc.2003.50060 Wechalekar, 2008, AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome, Blood, 112, 4009, 10.1182/blood-2008-02-138156 Palladini, 2009, AL amyloidosis associated with IgM monoclonal protein: a distinct clinical entity, Clin Lymphoma Myeloma, 9, 80, 10.3816/CLM.2009.n.021 Gertz, 2011, IgM amyloidosis: clinical features in therapeutic outcomes, Clin Lymphoma Myeloma Leuk, 11, 146, 10.3816/CLML.2011.n.034 Terrier, 2008, The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients, Medicine (Baltimore), 87, 99, 10.1097/MD.0b13e31816c43b6 Palladini, 2012, New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes, J Clin Oncol, 30, 4541, 10.1200/JCO.2011.37.7614 Kyle, 2011, IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM), Clin Lymphoma Myeloma Leuk, 11, 74, 10.3816/CLML.2011.n.011 Kyle, 2012, Progression in smoldering Waldenstrom macroglobulinemia: long-term results, Blood, 119, 4462, 10.1182/blood-2011-10-384768 Palladini, 2003, Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis, Circulation, 107, 2440, 10.1161/01.CIR.0000068314.02595.B2 Palladini, 2012, Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure, Am J Hematol, 87, 465, 10.1002/ajh.23141 Gertz, 2012, Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management, Am J Hematol, 87, 503, 10.1002/ajh.23192 Palladini, 2010, Diagnostic performance of immuno-electron microscopy of abdominal fat in systemic amyloidoses, Amyloid, 17, 59 Foli, 2011, The role of minor salivary gland biopsy in the diagnosis of systemic amyloidosis: results of a prospective study in 62 patients, Amyloid, 18, 75 Satoskar, 2007, Typing of amyloidosis in renal biopsies: diagnostic pitfalls, Arch Pathol Lab Med, 131, 917, 10.5858/2007-131-917-TOAIRB Schönland, 2012, Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients, Blood, 119, 488, 10.1182/blood-2011-06-358507 Arbustini, 2002, Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis, Amyloid, 9, 108, 10.3109/13506120208995243 Lavatelli, 2008, Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue, Mol Cell Proteomics, 7, 1570, 10.1074/mcp.M700545-MCP200 Lavatelli, 2011, Mass spectrometry-based proteomics as a diagnostic tool when immunoelectron microscopy fails in typing amyloid deposits, Amyloid, 18, 59 Vrana, 2009, Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens, Blood, 114, 4957, 10.1182/blood-2009-07-230722 Brambilla, 2012, Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue, Blood, 119, 1844, 10.1182/blood-2011-07-365510 Lachmann, 2002, Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis, N Engl J Med, 346, 1786, 10.1056/NEJMoa013354 Dispenzieri, 2004, Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis, J Clin Oncol, 22, 3751, 10.1200/JCO.2004.03.029 Kumar, 2012, Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements, J Clin Oncol, 30, 989, 10.1200/JCO.2011.38.5724